Literature DB >> 8549703

Serologic response to rickettsial antigens in patients with Astrakhan fever.

M E Eremeeva1, N M Balayeva, V F Ignatovich, D Raoult.   

Abstract

Astrakhan fever is a new spotted fever group (SFG) rickettsiosis. Sera of patients with Astrakhan fever have been examined by microimmunofluorescence and western immunoblotting to determine the serologic responses to the Astrakhan strain and to R. conorii M-1 strain and the Israelian isolate of SFG rickettsiae. The serologic response to specific rickettsial agent and to Israelian isolate has been found to be similar, but was different of that to R. conorii. Immunoglobulin G (IgG) and IgM antibodies were detected in most sera and were directed against the lipopolysaccharide. Only one of tested sera contained IgG antibodies which also recognized high molecular weight proteins.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549703     DOI： 10.1007/bf01721221

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  18 in total

1.  Astrakhan fever, a spotted-fever rickettsiosis.

Authors:  I V Tarasevich; V A Makarova; N F Fetisova; A V Stepanov; E D Miskarova; N Balayeva; D Raoult
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

2.  Neutralizing activity of monoclonal antibodies to heat-sensitive and heat-resistant epitopes of Rickettsia rickettsii surface proteins.

Authors:  R L Anacker; G A McDonald; R H List; R E Mann
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  Protective monoclonal antibodies recognize heat-labile epitopes on surface proteins of spotted fever group rickettsiae.

Authors:  H Li; B Lenz; D H Walker
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Determination of total protein.

Authors:  G L Peterson
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  The isolation of strains of rickettsiae of the spotted fever group in Israel and their differentiation from other members of the group by immunofluorescence methods.

Authors:  R A Goldwasser; Y Steiman; W Klingberg; T A Swartz; M A Klingberg
Journal:  Scand J Infect Dis       Date:  1974

7.  Fatal Israeli spotted fever in children.

Authors:  P Yagupsky; B Wolach
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

8.  Astrakhan fever rickettsiae: antigenic and genotypic analysis of isolates obtained from human and Rhipicephalus pumilio ticks.

Authors:  M E Eremeeva; L Beati; V A Makarova; N F Fetisova; I V Tarasevich; N M Balayeva; D Raoult
Journal:  Am J Trop Med Hyg       Date:  1994-11       Impact factor: 2.345

9.  Proteinic and genomic identification of spotted fever group rickettsiae isolated in the former USSR.

Authors:  M E Eremeeva; N M Balayeva; V F Ignatovich; D Raoult
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

10.  Serological response of patients suffering from primary and recrudescent typhus: comparison of complement fixation reaction, Weil-Felix test, microimmunofluorescence, and immunoblotting.

Authors:  M E Eremeeva; N M Balayeva; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
View more
  3 in total

Review 1.  Tick-borne rickettsioses around the world: emerging diseases challenging old concepts.

Authors:  Philippe Parola; Christopher D Paddock; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 2.  Rickettsioses as paradigms of new or emerging infectious diseases.

Authors:  D Raoult; V Roux
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

3.  Identification of Borrelia burgdorferi sensu lato, Anaplasma and Ehrlichia species, and spotted fever group Rickettsiae in ticks from Southeastern Europe.

Authors:  I Christova; J Van De Pol; S Yazar; E Velo; L Schouls
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-21       Impact factor: 3.267
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.